Advertisement
Screener

VIATRIS INC. (VTRS) Pre-Tax Margin

Viatris Inc Pre-Tax Margin

Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Viatris Inc pre-tax margin for the quarter ending 2026-06-30 was -1.71%, a change of 4.37% year-over-year.
  • Viatris Inc pre-tax margin for the quarter ending 2026-03-31 was -7.05%, a change of 88.45% year-over-year.
  • Viatris Inc pre-tax margin for the quarter ending 2025-12-31 was -9.29%, a change of 5.68% year-over-year.
  • Viatris Inc pre-tax margin for the quarter ending 2025-09-30 was -0.21%, a 108.71% decline year-over-year.
  • Viatris Inc pre-tax margin for fiscal 2025 was -25.72%, a change of -21.48% from fiscal 2024.
  • Viatris Inc pre-tax margin for fiscal 2024 was -4.24%, a 421.69% decline from fiscal 2023.
  • Viatris Inc pre-tax margin for fiscal 2023 was 1.32%, a 92.40% decline from fiscal 2022.
  • Viatris Inc pre-tax margin for fiscal 2022 was 17.35%, a change of 21.08% from fiscal 2021.
Available history
2018-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2026-06-30-1.71%-$64M$3.75B
2026-03-31-7.05%-$247.3M$3.51B
2025-12-31-9.29%-$343M$3.69B
2025-09-30-0.21%-$7.9M$3.75B
2025-06-30-6.08%-$217.1M$3.57B
2025-03-31-95.49%-$3.1B$3.24B
2024-12-31-14.98%-$526.5M$3.52B
2024-09-302.42%$90.5M$3.74B
2024-06-30-10.35%-$391.8M$3.79B
2024-03-315.60%$204.6M$3.65B
2023-12-31-22.35%-$855M$3.83B
2023-09-3010.22%$402.2M$3.93B
2023-06-308.52%$333M$3.91B
2023-03-318.68%$322.7M$3.72B
2022-12-3137.98%$1.47B$3.87B
2022-09-3010.51%$427.5M$4.07B
2022-06-309.48%$389.3M$4.11B
2022-03-3112.63%$527.5M$4.18B
2021-12-31-4.71%-$203.9M$4.33B
2021-09-304.42%$199.9M$4.52B
2021-06-30-4.80%-$219.1M$4.56B
2021-03-31-10.03%-$441.3M$4.4B
2020-12-31-28.25%-$1.01B$3.59B
2020-09-308.20%$241.6M$2.95B
2020-06-300.74%$20M$2.7B
2020-03-311.19%$30.7M$2.59B

Annual Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2025-12-31-25.72%-$3.67B$14.25B
2024-12-31-4.24%-$623.2M$14.69B
2023-12-311.32%$202.9M$15.39B
2022-12-3117.35%$2.81B$16.22B
2021-12-31-3.73%-$664.4M$17.81B
2020-12-31-6.10%-$721.2M$11.82B
2019-12-311.36%$154.4M$11.37B
2018-12-312.65%$298.4M$11.27B

Similar stocks

Stock NameCountryMarket CapPE Ratio
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17